Therapeutic strategies for SAPHO syndrome

Bibliography

• Chamot AM, Benhamou CL, Kahn MF, et al. Acne-pustulosis-hyperostosis-osteitis syndrome: results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 1987;54:187-96
   PubMedGoogle Scholar
• Trotta F, La Corte R, Bajocchi G, Manicardi S. Hyperostosis and multifocal osteitis: a purely rheumatological subset of SAPHO syndrome. Clin Exp Rheumatol 1990;8:401-4
   PubMedGoogle Scholar
• Hayem G, Bouchard-Chabot A, Benali K, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999;29:159-71
   PubMed Web of Science ®Google Scholar
• Colina M, Govoni M, Orzincolo C, Trotta F. Clinical and radiologic evolution of SAPHO syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 2009;61:813-21
   PubMed Web of Science ®Google Scholar
• Van Doornum S, Barraclough D, McColl G, Wicks I. SAPHO: rare or just not recognized? Semin Arthritis Rheum 2000;30:70-7
   PubMed Web of Science ®Google Scholar
• Kahn MF, Khan MA. The SAPHO syndrome. Baillieres Clin Rheumatol 1994;8:333-62
   PubMed Web of Science ®Google Scholar
• Nguyen MT, Borchers A, Selmi C, et al. The SAPHO syndrome. Semin Arthritis Rheum 2012;42:254-65
   PubMed Web of Science ®Google Scholar
• Dharancy S, Talbodec N, Asselah T, et al. The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn's disease. Presentation of 1 case and review of the literature. Gastroenterol Clin Biol 1998;22:240-3
   PubMedGoogle Scholar
• Van der Kloot WA, Chotkan SA, Kaptein AA, Hamdy NA. Diagnostic delay in sternocostoclavicular hyperostosis: impact on various aspects of quality of life. Arthritis Care Res 2010;62:251-7
   Google Scholar
• Colina M, Govoni M, Trotta F, Orzincolo C. Sternocostoclavicular hyperostosis and the impact of diagnostic delay: comment on the article by van der Kloot et al. Arthritis Care Res 2010;62:1513-14
   Google Scholar
• Schilling F, Kessler S. The SAPHO syndrome: clinical and radiological differentiation and classification on the basis of 86 cases. Z Rheumatol 2000;59:1-28
   PubMed Web of Science ®Google Scholar
• Kahn MF. SAPHO syndrome. ACR 67th Annual Scientific Meeting; Orlando; 2003
   Google Scholar
• Perry AL, Lambert PA. Propionibacterium acnes. Lett Appl Microbiol 2006;42:185-8
   PubMed Web of Science ®Google Scholar
• Colina M, Lo Monaco A, Khodeir M, Trotta F. Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol 2007;25:457-60
   PubMed Web of Science ®Google Scholar
• Assmann G, Simon P. The SAPHO syndrome: are microbes involved? Best Pract Res Clin Rheumatol 2011;25:423-34
   PubMed Web of Science ®Google Scholar
• Schaeverbeke T, Lequen L, De Barbeyrac B, et al. Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis. Arthritis Rheum 1998;41:1889-93
   PubMed Web of Science ®Google Scholar
• Komiya K, Yamada H, Terada N, et al. Expression of tumor necrosis factor-alpha converting enzymeand matrix metalloproteinase-3 in proliferated synovium ina patient with synovitis-acne-pustulosis-hyperostosis-osteitissyndrome: a case report. J Med Case Reports 2009;3:9123
   Google Scholar
• Albert HB, Lambert P, Rollason J, et al. Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae? Eur Spine J 2013;22:690-6
   PubMed Web of Science ®Google Scholar
• Jappe U, Boit R, Farrar MD, et al. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory. J Eur Acad Dermatol Venereol 2004;18:450-4
   PubMedGoogle Scholar
• Kalis C, Gumenscheimer M, Freudenberg N, et al. Requirement of TLR9 in the immunomodulatory activity of P.acnes. J Immunol 2005;174:4295-300
   PubMedGoogle Scholar
• Gonzalez T, Gantes M, Bustabad S, Diaz-Flores L. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol 1985;12:389-91
   PubMedGoogle Scholar
• Riffat G, Alexandre C, Pallot-Prades B, et al. A propos d'une observation familiale de SAPHO. Rhumatologie 1991;43:159-63
   Google Scholar
• Jansson A, Renner ED, Ramser J, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology 2007;46:154-60
   PubMed Web of Science ®Google Scholar
• Hurtado-Nedelec M, Chollet-Martin S, Chapeton D, et al. Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J Rheumatol 2010;37:401-9
   PubMedGoogle Scholar
• Colina M, Pippucci T, Moro MA, et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome: is PTPN22 involved? Clin Exp Rheumatol 2011;30-451
   Google Scholar
• Assmann G, Wagner AD, Monika M, et al. Single-nucleotide polymorphisms p53G72C and Mdm2T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int 2010;30:1273-6
   PubMedGoogle Scholar
• Ferguson PJ, Lokuta MA, El-Shanti HI, et al. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum 2008;58:3264-9
   PubMedGoogle Scholar
• Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007;19:492-8
   PubMed Web of Science ®Google Scholar
• Hayem G. Valuable lesson from SAPHO syndrome. Joint Bone Spine 2007;74:123-6
   PubMed Web of Science ®Google Scholar
• Amital H, Govoni M, Maya R, et al. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 2008;26(Suppl 48):S27-32
   Google Scholar
• Kirchhoff T, Merkesdal S, Rosenthal H, et al. Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up. Eur Radiol 2003;13:2304-8
   PubMed Web of Science ®Google Scholar
• Assmann G, Kueck O, Kirchhoff T, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009;11:R140
   PubMed Web of Science ®Google Scholar
• Kalke S, Perera SD, Patel ND, et al. The sternoclavicular syndrome: experience from a district general hospital and results of a national postal survey. Rheumatology 2001;40:170-7
   PubMedGoogle Scholar
• Eleftheriou D, Gerschman T, Sebire N, et al. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology 2010;49:1505-12
   PubMed Web of Science ®Google Scholar
• Jurik AG. Seronegative arthritides of the anterior chest wall: a follow-up study. Skel Radiol 1991;20:517-25
   PubMedGoogle Scholar
• Schultz C, Holterus PM, Seidel A, et al. Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J 1999;18:1008-13
   PubMedGoogle Scholar
• Jung J, Molinger M, Kohn D, et al. Intra-articular glucocorticosteroid injection into sternocostoclavicular joints in Patients with SAPHO Syndrome. Semin Arthritis Rheum 2012;42:266-70
   PubMed Web of Science ®Google Scholar
• Freyschmidt J, Sternberg A. The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur Radiol 1998;8:807-12
   PubMed Web of Science ®Google Scholar
• Assmann G, Kueck O, Kirchhoff T, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009;11:R140
   PubMed Web of Science ®Google Scholar
• Tsuda T, Ishikawa C, Konishi H, et al. Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease activated receptor 2 in human keratinocytes. J Antimicrob Chemother 2001;52:1538-41
   Google Scholar
• Schilling F, Wagner AD. Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. Z Rheumatology 2000;59:352-3
   PubMedGoogle Scholar
• Schilling F. SAPHO syndrome. Orphanet encyclopedia. Available from: http://www.orpha.net/data/patho/GB/uk-SAPHO.pdf [Last accessed October 2004]
   Google Scholar
• Wagner AD, Andresen J, Huelsemann J, Zeidler H. Long-term antibiotic therapy successful in patients with SAPHO syndrome. Arthritis Rheum 1997;40:S62
   PubMedGoogle Scholar
• Ballara SC, Siraj QH, Maini RN, Venables PJ. Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum 1999;42:819-21
   PubMed Web of Science ®Google Scholar
• Rozin AP, Nahir AM. Is SAPHO syndrome a target for antibiotic tharapy? Clin Rheumatol 2007;26:817-20
   PubMedGoogle Scholar
• Mochizuki Y, Omura K, Hirai H, et al. Chronic mandibular osteomyelitis with suspected underlying synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: a case report. J Inflamm Res 2012;5:29-35
   PubMedGoogle Scholar
• Rozin AP. SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended? Arthritis Res Ther 2009;11:131
   PubMed Web of Science ®Google Scholar
• Köhler H, Uehlinger E, Kutzner J, West TB. Sternocostoclavicular. hyperostosis: painful swelling of the sternum, clavicles, and upper ribs. Ann Intern Med 1977;87:192-4
   PubMedGoogle Scholar
• Lissens M, Bruyninckx F, Rosselle N. Condensing osteitis of the clavicle. Report of two cases and review of the literature. Acta Belg Med Phys 1990;13:235-40
   PubMedGoogle Scholar
• Misaki T, Dokoh S, Mori E. Calcitonin treatment for intersternocostoclavicular ossification: clinical experience in two cases. Ann Rheum Dis 1991;50:813-16
   PubMed Web of Science ®Google Scholar
• Green JR. Antitumor effects of bisphosphonates. Cancer 2003;97(Suppl 3):840-7
   PubMedGoogle Scholar
• Russel RGG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25:97-106
   PubMed Web of Science ®Google Scholar
• Courtney PA, Hosking DJ, Fairburn KJ, Deighton CM. Treatment of SAPHO with pamidronate. Rheumatology 2002;41:1196-8
   PubMed Web of Science ®Google Scholar
• Marshall H, Bromilow J, Thomas AL, Arden NK. Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 2002;41:231-3
   PubMed Web of Science ®Google Scholar
• Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002;69:392-6
   PubMed Web of Science ®Google Scholar
• Amital H, Applbaum YH, Aamar S, et al. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology 2004;43:658-61
   PubMed Web of Science ®Google Scholar
• Kerrison C, Davidson JE, Cleary AG, Beresford MW. Pamidronate. in the treatment of childhood SAPHO syndrome. Rheumatology 2004;43:1246-51
   PubMed Web of Science ®Google Scholar
• Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009;27:112-15
   PubMed Web of Science ®Google Scholar
• Ringe JD, Faber H, Farahmand P. Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy. J Bone Miner Metab 2006;24:87-93
   PubMedGoogle Scholar
• Soyfoo MS, Gangji V, Margaux J. Successful treatment of SAPHO syndrome with ibandronate. J Clin Rheumatol 2010;16:253
   PubMed Web of Science ®Google Scholar
• Kopterides P, Pikazis D, Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 2004;50:2970-3
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Cantarini L, Burroni L, et al. Efficacy of alendronate in the treatment of the SAPHO syndrome. J Clin Rheumatol 2008;14:183-4
   PubMedGoogle Scholar
• Ichikawa J, Sato E, Haro H, et al. Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int 2009;29:713
   PubMedGoogle Scholar
• Olivieri I, Padula A, Palazzi C. Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs 2006;15:1229-33
   PubMed Web of Science ®Google Scholar
• Ben Abdelghani K, Dran DG, Gottenberg JE, et al. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol 2010;37:1699-704
   PubMed Web of Science ®Google Scholar
• Burgemeister LT, Baeten DLP, Tas SW. Biologics for rare inflammatory diseases: TNF blockade in the SAPHO syndrome. Ned J Med 2012;70:444-9
   PubMed Web of Science ®Google Scholar
• Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology 2008;47:1160-7
   PubMed Web of Science ®Google Scholar
• Wagner AD, Andresen J, Jendro MC, et al. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002;46:1965-8
   PubMed Web of Science ®Google Scholar
• Olivieri I, Padula A, Ciancio G, et al. Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 2002;61:375-6
   PubMed Web of Science ®Google Scholar
• Deutschmann A, Mache CJ, Bodo K, et al. Successful treatment of CRMO with tumor necrosis factor-alpha blockage. Pediatrics 2005;116:1231-3
   PubMed Web of Science ®Google Scholar
• Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 2006;45:730-3
   PubMed Web of Science ®Google Scholar
• Sabugo F, Liberman C, Niedmann JP, et al. Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism. Clin Rheumatol 2008;27:533-5
   PubMed Web of Science ®Google Scholar
• Castellvi I, Bonet M, Narváez JA, Molina-Hinojosa JC. Successful treatment of SAPHO syndrome with adalimumab: a case report. Clin Rheumatol 2010;29:1205-7
   PubMed Web of Science ®Google Scholar
• Zhang LL, Zhao JX, Liu XY. Successful treatment of SAPHO syndrome with severe spinal disorder using etanercept: a case study. Theumatol Int 2012;32:1916-19
   Google Scholar
• Fruehauf J, Cierni-Modré B, Caelen L, et al. Response to infliximab in SAPHO syndrome. BMJ Case Rep 2009; doi: 10.1136/bcr.10.2008.1145
   PubMedGoogle Scholar
• Roux CH, Brocq O, Leccia N, et al. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect? J Rheumatol 2007;34:434-7
   PubMed Web of Science ®Google Scholar
• Colina M, Pizzirani C, Khodeir M, et al. Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology 2010;49:1416-18
   PubMed Web of Science ®Google Scholar
• Wendling D, Prati C, Aubin F. Anakinra treatment of. SAPHO syndrome: short term results of an open study. Ann Rheum Dis 2012;7:1098-100
   Google Scholar
• Montonen M, Iizuka T, Hallikainen D, Lindqvist C. Decortication in the treatment of diffuse sclerosing osteomyelitis of the mandible. Retrospective analysis of 41 cases between 1969 and 1990. Oral Surg Oral Med Oral Pathol 1993;75:5-11
   PubMedGoogle Scholar
• Eyrich GK, Harder C, Sailer HF, et al. Primary chronic osteomyelitis associated with synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO syndrome). J Oral Pathol Med 1999;28:456-64
   PubMedGoogle Scholar
• Wanders A, van der Heijde D, Landewé R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52:1756-65
   PubMed Web of Science ®Google Scholar
• Stirling A, Worthington T, Rafiq M, et al. Association between sciatica and Propionibacterium Acnes. Lancet 2001;357:2024-5
   PubMed Web of Science ®Google Scholar